Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.020
-0.070 (-6.42%)
Dec 20, 2024, 4:00 PM EST - Market closed
Context Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 76 | 18 | 10 | 42 | - | - |
| Market Cap Growth | 509.72% | 73.39% | -75.50% | - | - | - |
| Enterprise Value | -8 | -4 | -29 | 63 | - | - |
| Last Close Price | 1.02 | 1.13 | 0.65 | 2.66 | - | - |
| PB Ratio | 0.91 | 1.52 | 0.30 | 0.88 | - | - |
| P/TBV Ratio | 1.75 | 1.52 | 0.30 | 0.88 | - | - |
| Debt / Equity Ratio | 0.00 | - | 0.00 | - | -0.65 | -0.91 |
| Quick Ratio | 36.36 | 3.45 | 11.07 | 16.36 | 0.03 | 0.01 |
| Current Ratio | 36.91 | 3.83 | 11.80 | 16.90 | 0.03 | 0.01 |
| Return on Equity (ROE) | -58.98% | -102.79% | -35.74% | -53.50% | - | - |
| Return on Assets (ROA) | -37.22% | -58.01% | -20.84% | -17.96% | -433.97% | - |
| Return on Capital (ROIC) | -39.70% | -67.13% | -22.39% | -20.64% | - | - |
| Earnings Yield | -39.42% | -132.83% | -142.58% | -24.63% | - | - |
| FCF Yield | -22.07% | -116.66% | -130.57% | -20.72% | - | - |
| Buyback Yield / Dilution | -162.59% | - | -463.44% | -37.90% | - | - |
| Total Shareholder Return | -162.59% | - | -463.44% | -37.90% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.